Novel materials made with FDA-approved components could deliver large payloads of active ingredients.
MIT chemical engineers have devised a new way to create very tiny droplets of one liquid suspended within another liquid, known as nanoemulsions. Such emulsions are similar to the mixture that forms when you shake an oil-and-vinegar salad dressing, but with much smaller droplets. Their tiny size allows them to remain stable for relatively long periods of time.
The researchers also found a way to easily convert the liquid nanoemulsions to a gel when they reach body temperature (37 degrees Celsius), which could be useful for developing materials that can deliver medication when rubbed on the skin or injected into the body.
“The pharmaceutical industry is hugely interested in nanoemulsions as a way of delivering small molecule therapeutics. That could be topically, through ingestion, or by spraying into the nose, because once you start getting into the size range of hundreds of nanometers you can permeate much more effectively into the skin,” says Patrick Doyle, the Robert T. Haslam Professor of Chemical Engineering and the senior author of the study.
In their new study, which appears in the June 21 issue of Nature Communications, the researchers created nanoemulsions that were stable for more than a year. To demonstrate the emulsions’ potential usefulness for delivering drugs, the researchers showed that they could incorporate ibuprofen into the droplets.
Seyed Meysam Hashemnejad, a former MIT postdoc, is the first author of the study. Other authors include former postdoc Abu Zayed Badruddoza, L’Oréal senior scientist Brady Zarket, and former MIT summer research intern Carlos Ricardo Castaneda.
One of the easiest ways to create an emulsion is to add energy — by shaking your salad dressing, for example, or using a homogenizer to break down fat globules in milk. The more energy that goes in, the smaller the droplets, and the more stable they are.
Nanoemulsions, which contain droplets with a diameter 200 nanometers or smaller, are desirable not only because they are more stable, but they also have a higher ratio of surface area to volume, which allows them to carry larger payloads of active ingredients such as drugs or sunscreens.
Over the past few years, Doyle’s lab has been working on lower-energy strategies for making nanoemulsions, which could make the process easier to adapt for large-scale industrial manufacturing.
Detergent-like chemicals called surfactants can speed up the formation of emulsions, but many of the surfactants that have previously been used for creating nanoemulsions are not FDA-approved for use in humans. Doyle and his students chose two surfactants that are uncharged, which makes them less likely to irritate the skin, and are already FDA-approved as food or cosmetic additives. They also added a small amount of polyethylene glycol (PEG), a biocompatible polymer used for drug delivery that helps the solution to form even smaller droplets, down to about 50 nanometers in diameter.
“With this approach, you don’t have to put in much energy at all,” Doyle says. “In fact, a slow stirring bar almost spontaneously creates these super small emulsions.”
Active ingredients can be mixed into the oil phase before the emulsion is formed, so they end up loaded into the droplets of the emulsion.
Once they had developed a low-energy way to create nanoemulsions, using nontoxic ingredients, the researchers added a step that would allow the emulsions to be easily converted to gels when they reach body temperature. They achieved this by incorporating heat-sensitive polymers called poloxamers, or Pluronics, which are already FDA-approved and used in some drugs and cosmetics.
Pluronics contain three “blocks” of polymers: The outer two regions are hydrophilic, while the middle region is slightly hydrophobic. At room temperature, these molecules dissolve in water but do not interact much with the droplets that form the emulsion. However, when heated, the hydrophobic regions attach to the droplets, forcing them to pack together more tightly and creating a jelly-like solid. This process happens within seconds of heating the emulsion to the necessary temperature.
The researchers found that they could tune the properties of the gels, including the temperature at which the material becomes a gel, by changing the size of the emulsion droplets and the concentration and structure of the Pluronics that they added to the emulsion. They can also alter traits such as elasticity and yield stress, which is a measure of how much force is needed to spread the gel.
Doyle is now exploring ways to incorporate a variety of active pharmaceutical ingredients into this type of gel. Such products could be useful for delivering topical medications to help heal burns or other types of injuries, or could be injected to form a “drug depot” that would solidify inside the body and release drugs over an extended period of time. These droplets could also be made small enough that they could be used in nasal sprays for delivering inhalable drugs, Doyle says.
For cosmetic applications, this approach could be used to create moisturizers or other products that are more shelf-stable and feel smoother on the skin.
The Latest on: Nanoemulsions
via Google News
The Latest on: Nanoemulsions
- SureNano Science Signs Licensing Agreement for the State of Oklahomaon June 27, 2022 at 4:00 am
SURENANO SCIENCE LTD. (CSE: SURE) (the "Company" or "SureNano") is pleased to announce that it has signed a licensing agreement with 1150641 BC Ltd. ("1150641") for the exclusive rights to sell and ...
- Nanopesticide Market Size In 2022 with Top Countries Data : What is the growth rate of the Industry? | In-Depth Analysis with 95 Report Pageson June 27, 2022 at 12:28 am
Nanopesticide Market In 2022 (Short Description) : Nanopesticides are pesticides whose formulation uses nanotechnology ...
- Eastgate Biotech (OTCMKTS:ETBI) Shares Pass Above Fifty Day Moving Average of $0.00on June 24, 2022 at 10:56 pm
Shares of Eastgate Biotech Corp. (OTCMKTS:ETBI – Get Rating) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as ...
- InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Potential of UST(TM) as ‘Essential Tool in Future Beverage Development’on June 14, 2022 at 2:12 pm
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and process development services to the worldwide food and ...
- Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Marketon June 14, 2022 at 6:47 am
While we have previously demonstrated that UST makes fantastic nanoemulsions, there are even more applications where microemulsions as well as nano/micro suspensions are practical and useful for ...
- Pressure BioSciences’ Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Marketon June 14, 2022 at 4:32 am
Recent Study Published by The Ohio State University Illuminates Unique Capabilities of PBI’s UST Platform for Optimal Formulation and Processing of New and Existing Plant Protein-based Beverages SOUTH ...
- Self-nanoemulsifying Drug Delivery Systems: Formulation Insights, Applications and Advanceson June 8, 2022 at 5:00 pm
The methods used for fabrication of the nanoemulsions (Figure 1) are divided into high-energy emulsification methods or low-energy emulsification methods. As the name suggests, high-energy ...
- Investornewsbreaks Pressure Biosciences Inc. (PBIO) CEO Discusses UST(TM) Platform, Early Access Program On Stock Day Podcaston June 1, 2022 at 10:08 pm
Schumacher joined Stock Day host Sever Copley to discuss PBI's Ultra Shear Technology(TM)(“UST(TM)”) for the processing of nanoemulsions. The company has seven issued UST patents to date ...
- Global Nanoemulsions Market 2022 - In-Depth Analysis, Growth Statistics, Upcoming Trends and Growth Opportunities to 2028on May 30, 2022 at 5:12 am
May 29, 2022 (CDN Newswire via Comtex) -- MarketsandResearch.biz has recommended the addition of a new record designated Global Nanoemulsions Market 2022 by Company, Regions, Type and Application ...
- Investornewsbreaks Pressure Biosciences Inc. (PBIO) Enters First UST Early Access Manufacturing Agreementon May 4, 2022 at 1:38 pm
According to the announcement, all products discussed in the contract will include high-quality nanoemulsions of oils in water produced by using PBI's revolutionary UST platform. The final ...
via Bing News